These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1043 related articles for article (PubMed ID: 16876156)
1. EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats. Desai KM; Gopalakrishnan V; Hiebert LM; McNeill JR; Wilson TW Eur J Pharmacol; 2006 Sep; 546(1-3):120-6. PubMed ID: 16876156 [TBL] [Abstract][Full Text] [Related]
2. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF. Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786 [TBL] [Abstract][Full Text] [Related]
3. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations. El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975 [TBL] [Abstract][Full Text] [Related]
5. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis. Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed. McCulloch AI; Randall MD Br J Pharmacol; 1998 Apr; 123(8):1700-6. PubMed ID: 9605578 [TBL] [Abstract][Full Text] [Related]
7. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats. Resende AC; Pimentel AM; de Moura RS Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389 [TBL] [Abstract][Full Text] [Related]
8. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses. López RM; Pérez T; Castillo C; Castillo MC; Castillo EF Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990 [TBL] [Abstract][Full Text] [Related]
9. Evidence for an endothelium-derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosis. Barriere E; Tazi KA; Rona JP; Pessione F; Heller J; Lebrec D; Moreau R Hepatology; 2000 Nov; 32(5):935-41. PubMed ID: 11050042 [TBL] [Abstract][Full Text] [Related]
10. Clofibrate acutely reverses saline-induced endothelial dysfunction: role of calcium-activated potassium channels. Sankaralingam S; Desai KM; Wilson TW Am J Hypertens; 2006 Nov; 19(11):1167-73. PubMed ID: 17070430 [TBL] [Abstract][Full Text] [Related]
11. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade. Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863 [TBL] [Abstract][Full Text] [Related]
12. Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. Shi Y; Ku DD; Man RY; Vanhoutte PM J Pharmacol Exp Ther; 2006 Jul; 318(1):276-81. PubMed ID: 16565165 [TBL] [Abstract][Full Text] [Related]
13. Endothelial mediators of the acetylcholine-induced relaxation of the rat femoral artery. Leung HS; Leung FP; Yao X; Ko WH; Chen ZY; Vanhoutte PM; Huang Y Vascul Pharmacol; 2006 May; 44(5):299-308. PubMed ID: 16527547 [TBL] [Abstract][Full Text] [Related]
14. Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo. Fitzgerald SM; Bashari H; Cox JA; Parkington HC; Evans RG Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1072-82. PubMed ID: 17468338 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Pannirselvam M; Ding H; Anderson TJ; Triggle CR Eur J Pharmacol; 2006 Dec; 551(1-3):98-107. PubMed ID: 17027963 [TBL] [Abstract][Full Text] [Related]
16. The role of NO-cGMP pathway and potassium channels on the relaxation induced by clonidine in the rat mesenteric arterial bed. Pimentel AM; Costa CA; Carvalho LC; Brandão RM; Rangel BM; Tano T; Soares de Moura R; Resende AC Vascul Pharmacol; 2007 May; 46(5):353-9. PubMed ID: 17258511 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide modulation of endothelium-derived hyperpolarizing factor in agonist-induced depressor responses in anesthetized rats. Kobuchi S; Miura K; Iwao H; Ayajiki K Eur J Pharmacol; 2015 Sep; 762():26-34. PubMed ID: 25962662 [TBL] [Abstract][Full Text] [Related]
18. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Brandes RP; Schmitz-Winnenthal FH; Félétou M; Gödecke A; Huang PL; Vanhoutte PM; Fleming I; Busse R Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9747-52. PubMed ID: 10944233 [TBL] [Abstract][Full Text] [Related]
19. Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats. Jiang F; Dusting GJ Br J Pharmacol; 2001 Apr; 132(7):1558-64. PubMed ID: 11264250 [TBL] [Abstract][Full Text] [Related]
20. Vascular acetylcholine response during chronic NO synthase inhibition: in vivo versus in vitro. Zanchi A; Aubert JF; Brunner HR; Waeber B Cardiovasc Res; 1995 Jul; 30(1):122-9. PubMed ID: 7553714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]